United States life tables, 2004 - PubMed (original) (raw)
. 2007 Dec 28;56(9):1-39.
Affiliations
- PMID: 18274319
Free article
United States life tables, 2004
Elizabeth Arias. Natl Vital Stat Rep. 2007.
Free article
Abstract
This report presents period life tables for the United States based on age-specific death rates in 2004. Data used to prepare these life tables are 2004 final mortality statistics; July 1, 2004, population estimates based on the 2000 decennial census and data from the Medicare program. Presented are complete life tables by age, race, and sex. In 2004, the overall expectation of life at birth was 77.8 years, representing an increase of 0.4 year from life expectancy in 2003. Between 2003 and 2004, life expectancy increased for males and females, and for both the white and black populations. Life expectancy increased by 0.5 years (from 72.6 to 73.1) for the black population and by 0.4 year (from 77.9 to 78.3) for the white population. Both males and females in each race group experienced increases in life expectancy between 2003 and 2004. The greatest increase was experienced by black males with an increase of 0.6 year (from 68.9 to 69.5). Life expectancy increased by 0.4 year for black females (from 75.9 to 76.3), for white females (from 80.4 to 80.8), and for white males (from 75.3 to 75.7).
Similar articles
- United States life tables, 2003.
Arias E. Arias E. Natl Vital Stat Rep. 2006 Apr 19;54(14):1-40. Natl Vital Stat Rep. 2006. PMID: 16681183 - The effect of revised populations on mortality statistics for the United States, 2000.
Anderson RN, Arias E. Anderson RN, et al. Natl Vital Stat Rep. 2003 Jun 5;51(9):1-24. Natl Vital Stat Rep. 2003. PMID: 12795490 - United States life tables, 2002.
Arias E. Arias E. Natl Vital Stat Rep. 2004 Nov 10;53(6):1-38. Natl Vital Stat Rep. 2004. PMID: 15580947 - [New trends in mortality and life expectancy: epidemiologic transition in Hungary?].
Józan P. Józan P. Orv Hetil. 2003 Mar 9;144(10):451-60. Orv Hetil. 2003. PMID: 12687794 Review. Hungarian. - Estimation of future mortality rates and life expectancy in chronic medical conditions.
Strauss DJ, Vachon PJ, Shavelle RM. Strauss DJ, et al. J Insur Med. 2005;37(1):20-34. J Insur Med. 2005. PMID: 15895695 Review.
Cited by
- Is dabigatran considered a cost-effective alternative to warfarin treatment: a review of current economic evaluations worldwide.
Hesselbjerg LJ, Pedersen HS, Asmussen MB, Petersen KD. Hesselbjerg LJ, et al. J Med Econ. 2013 Jul;16(7):845-58. doi: 10.3111/13696998.2013.800523. Epub 2013 May 15. J Med Econ. 2013. PMID: 23621506 Free PMC article. Review. - Cost-effectiveness of the 21-gene recurrence score assay in the context of multifactorial decision making to guide chemotherapy for early-stage breast cancer.
Reed SD, Dinan MA, Schulman KA, Lyman GH. Reed SD, et al. Genet Med. 2013 Mar;15(3):203-11. doi: 10.1038/gim.2012.119. Epub 2012 Sep 13. Genet Med. 2013. PMID: 22975761 Free PMC article. - Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost-utility analysis.
Cooperberg MR, Ramakrishna NR, Duff SB, Hughes KE, Sadownik S, Smith JA, Tewari AK. Cooperberg MR, et al. BJU Int. 2013 Mar;111(3):437-50. doi: 10.1111/j.1464-410X.2012.11597.x. Epub 2012 Dec 28. BJU Int. 2013. PMID: 23279038 Free PMC article. - Non-hispanic whites have higher risk for pulmonary impairment from pulmonary tuberculosis.
Pasipanodya JG, Vecino E, Miller TL, Munguia G, Drewyer G, Fernandez M, Slocum P, Weis SE. Pasipanodya JG, et al. BMC Public Health. 2012 Feb 10;12:119. doi: 10.1186/1471-2458-12-119. BMC Public Health. 2012. PMID: 22325005 Free PMC article. - Sex Differences in Outcome After Endovascular Stroke Therapy for Acute Ischemic Stroke.
Sheth SA, Lee S, Warach SJ, Gralla J, Jahan R, Goyal M, Nogueira RG, Zaidat OO, Pereira VM, Siddiqui A, Lutsep H, Liebeskind DS, McCullough LD, Saver JL. Sheth SA, et al. Stroke. 2019 Sep;50(9):2420-2427. doi: 10.1161/STROKEAHA.118.023867. Epub 2019 Aug 15. Stroke. 2019. PMID: 31412752 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources